Mark Mofid Has Worked Tirelessly To Redefine His Industry:

Dr. Mark Mofid is a well-known figure in the medical field of cosmetics. He has studied at Harvard and John Hopkins University. Mark is known as a major innovator in his industry and is well trusted due to his strict compliance with medical safety practices. An area that Mark Mofid has been innovating in is gluteal augmentation. He sits at the forefront of this industry. A major factor for this is that he puts the safety of his patients at the forefront of everything he does. It is not uncommon for practitioners in the industry to simply look to make more money off of their patients by recommending bigger implants, but Mark Mofid takes the approach that a patients safety comes first.

Mark spends a large amount of his time doing research to find ways to better improve his practice. He relies on an innovative approach that is backed by science. Mark also has a reputation for always paying attention to detail and being a forward thinker. He has an in-depth knowledge of the body’s fat, muscle system and skin. Due to this, he is in a unique position as far as his ability to understand and think outside of the box.

Mark Mofid has been working tirelessly for the past eight years to develop the specific surgeries that he performs. He has always had the ability to recognize where opportunities for improvement existed. Mark Mofid does not want to just do things the way that they have been done previously and has set a goal to become the industry leader.

A major issue with gluteal augmentation has been the fact that a majority of implants were too generic and not specifically compatible with the muscle structure of the human body. Mark Mofid did not want to continue to work with an inferior product and sought to develop a new way. After numerous hours of research, Mark as able to create a truly outstanding gluteal implant. This is the reason that Mark is the leader in this industry. His patients can rest assured that they are working with a practitioner who is tirelessly striving to give them the best treatment possible.

https://medicalspamd.com/the-blog/2012/8/30/interview-dr-mark-mofid-a-plastic-surgeon-in-san-diego-calif.html

Drew Madden: Business In Healthcare And Pharmaceuticals

According to recent reports, healthcare is an attractive industry for most investors. The reports highlight CVS and Amazon battling to own the healthcare consumer. Both of the companies are making significant moves towards establishing business in healthcare. Recently, Amazon acquired license for distribution of healthcare related equipment in multiple states. The report also indicates the company’s intention to obtain more pharmacy licenses including distribution of prescription medication. On release of the report, several investors in the pharmaceutical industry shed their shares in bow of Amazon as a competitor in pharmaceutical sales.

 

Although Amazon has not clearly stated its intentions to venture in pharmaceutical sales, it is apparent from its moves and response of other firms in the industry. CVS for instance is acquiring Aetna as a first move in venturing in health insurance. The pharmaceutical company has also introduced next-day prescription delivery across the nation. These are indications of CVS preparations to compete with Amazon and maintain its market share.

 

Amazon venturing in pharmaceuticals is a game changer for existing firms in the industry. Reports indicate increasing innovation among key players in the industry. Pharmacy Benefit Managers (PBMs) are also enhancing their level of services to remain relevant in the industry. Amazon is a real threat to the industry because it is already a universal store across the United States. This offers it a wide consumer platform thus an upper hand in any new venture. Visit This Page for more information.

 

About Drew Madden

 

Drew Madden is a graduate in Industrial Engineering from University of Iowa College of Engineering. He specialized in Medical Systems. Madden began his career in IT entrepreneurship at Cerner Corporation. The Healthcare IT entrepreneur focuses on Electronic Medical Records (EMR) where he collaborates with professionals in healthcare and technology fields to solve complex challenges. Drew is renowned for building efficient teams and unique company cultures that attract prime clients and long-term partnerships.

Mr. Madden served as the president of Nordic Consulting Partners for five years. During this period, the company’s annual revenue grew from $1 million to $130 million. Additionally, employees number came up from 10 to 725 and client partners increased to 150.

 

See: https://www.nordicwi.com/about-nordic/our-team/

 

Elysium Health on Supporting Cellular Health

Elysium Health was founded in 2014 by Dr. Leonard Guarente. Dr. Guarente in addition to serving as the chief scientist at Elysium Health, is the director of the Paul F. Glenn Center for Biology of Aging Research at MIT.

 

Elysium Health works together with scientists from world-class universities like Harvard, Yale, and Stanford to translate advances in science and technology into clinically- validated health products that work. The mission of the company is help people live healthier, longer in the process.

 

Basis is the first supplement created by Elysium Health. Basis works to increase and sustain levels of NAD+ in our cells. NAD+ is a coenzyme essential to many of our cellular processes such as energy creation, DNA protection, circadian rhythms, and others. As we age, the levels of NAD+ decline naturally and those functions break down. Basis is designed to increase levels of NAD+ and, as a result, support our cellular health.

 

The formula for Basis is based on more than 25 years of aging research. A clinical trial conducted by Elysium Health in 2016 demonstrated that Basis increased levels of NAD+ in humans taking the recommended daily dose (two capsules) by an average of 40 percent over the course of several weeks.

 

Basis regularly undergoes third party testing for quality. This supplement is gluten-free, nut-free, vegetarian, and vegan, allowing you to stick to your diet while taking Basis.

 

Basis is available for purchase on Elysium Health’s website. A six-month subscription to Basis costs $270 ($45 per month) and a one-year subscription costs $480 ($40 per month). An ongoing monthly subscription costs $50 per month. You can also buy an individual bottle of Basis for $60.

 

Elysium is also in the process of developing new products that focus on the microbiome, cognitive health, skin health, muscle function, and circadian rhythms. These products are in various stages of pre-clinical and clinical trials.

 

For more information on Elysium Health’s team of scientists, the company itself, and the science behind the Basis, visit Elysium’s website. See This Page for related information.

 

Related: https://thehustle.co/elysium-health-wants-to-change-the-way-you-age